Larry Biegelsen
Stock Analyst at Wells Fargo
(3.82)
# 371
Out of 4,853 analysts
309
Total ratings
53.1%
Success rate
6.82%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Overweight | $118 → $93 | $71.18 | +30.65% | 17 | May 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $108 | $95.13 | +13.53% | 9 | May 21, 2025 | |
| RXST RxSight | Upgrades: Overweight | $17 → $25 | $14.90 | +67.79% | 13 | May 19, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $1.29 → $0.68 | $0.86 | -21.25% | 5 | May 14, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $113 → $98 | $91.92 | +6.61% | 10 | May 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $195 → $174 | $135.87 | +28.06% | 12 | May 6, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $146 → $137 | $122.16 | +12.15% | 5 | May 2, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $36 → $33 | $30.15 | +9.45% | 16 | May 2, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $15 → $12 | $11.61 | +3.36% | 6 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $103 → $89 | $71.55 | +24.39% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $20 | $20.66 | -3.17% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $160 → $86 | $92.69 | -7.22% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $315 | $258.38 | +21.91% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $20.29 | +38.00% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $118 | $102.83 | +14.75% | 13 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $13.28 | +28.01% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $427 → $435 | $383.10 | +13.55% | 15 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $630 → $687 | $558.06 | +23.11% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $153.66 | -1.08% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $2.97 | +169.36% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $85.74 | +9.63% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $87.00 | +12.64% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $77.77 | +2.87% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $86.93 | +20.79% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $16.45 | +143.16% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $13.30 | +268.56% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $133.94 | +1.54% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $59.55 | +17.55% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $171.03 | +57.87% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $80.33 | - | 2 | Nov 2, 2017 |
The Cooper Companies
May 30, 2025
Maintains: Overweight
Price Target: $118 → $93
Current: $71.18
Upside: +30.65%
Merit Medical Systems
May 21, 2025
Maintains: Overweight
Price Target: $106 → $108
Current: $95.13
Upside: +13.53%
RxSight
May 19, 2025
Upgrades: Overweight
Price Target: $17 → $25
Current: $14.90
Upside: +67.79%
Hyperfine
May 14, 2025
Maintains: Equal-Weight
Price Target: $1.29 → $0.68
Current: $0.86
Upside: -21.25%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $91.92
Upside: +6.61%
Inspire Medical Systems
May 6, 2025
Maintains: Equal-Weight
Price Target: $195 → $174
Current: $135.87
Upside: +28.06%
Teleflex
May 2, 2025
Maintains: Equal-Weight
Price Target: $146 → $137
Current: $122.16
Upside: +12.15%
Baxter International
May 2, 2025
Maintains: Equal-Weight
Price Target: $36 → $33
Current: $30.15
Upside: +9.45%
Bausch + Lomb
May 1, 2025
Maintains: Equal-Weight
Price Target: $15 → $12
Current: $11.61
Upside: +3.36%
GE HealthCare Technologies
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $71.55
Upside: +24.39%
May 1, 2025
Maintains: Equal-Weight
Price Target: $22 → $20
Current: $20.66
Upside: -3.17%
May 1, 2025
Downgrades: Equal-Weight
Price Target: $160 → $86
Current: $92.69
Upside: -7.22%
Apr 24, 2025
Maintains: Overweight
Price Target: $305 → $315
Current: $258.38
Upside: +21.91%
Mar 31, 2025
Initiates: Overweight
Price Target: $28
Current: $20.29
Upside: +38.00%
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $118
Current: $102.83
Upside: +14.75%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $13.28
Upside: +28.01%
Jan 29, 2025
Maintains: Overweight
Price Target: $427 → $435
Current: $383.10
Upside: +13.55%
Jan 24, 2025
Maintains: Overweight
Price Target: $630 → $687
Current: $558.06
Upside: +23.11%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $153.66
Upside: -1.08%
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $2.97
Upside: +169.36%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $85.74
Upside: +9.63%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $87.00
Upside: +12.64%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $77.77
Upside: +2.87%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $86.93
Upside: +20.79%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $16.45
Upside: +143.16%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $13.30
Upside: +268.56%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $133.94
Upside: +1.54%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $59.55
Upside: +17.55%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $171.03
Upside: +57.87%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $80.33
Upside: -